High-Dose Chemotherapy for Inflammatory Breast Cancer
Author Information
Author(s): Viens P, Palangié T, Janvier M, Fabbro M, Roché H, Delozier T, Labat J P, Linassier C, Audhuy B, Feuilhade F, Costa B, Delva R, Cure H, Rousseau F, Guillot A, Mousseau M, Ferrero J M, Bardou V J, Jacquemier J, Pouillart P
Primary Institution: Institut Paoli Calmettes
Hypothesis
Can high-dose sequential chemotherapy with repeated blood stem cell transplantation improve outcomes in untreated inflammatory breast cancer?
Conclusion
High-dose chemotherapy with repeated blood stem cell transplantation is feasible and shows encouraging pathological response rates in inflammatory breast cancer.
Supporting Evidence
- Ninety-five patients received four cycles of chemotherapy.
- Main toxicity was haematological with febrile neutropenia occurring in 26% to 51% of cycles.
- A total of 366 cycles of chemotherapy were administered.
- Eighty-seven patients completed the four cycles of chemotherapy.
- Pathological complete response rate in breast was 32% ± 10%.
Takeaway
This study looked at a special type of chemotherapy for women with a serious breast cancer, and it found that it can work well and is safe.
Methodology
The study involved 100 women receiving high-dose chemotherapy and blood stem cell transplantation, with evaluations of response and toxicity.
Limitations
The study had a small sample size and the results need confirmation through final outcomes.
Participant Demographics
Median age of participants was 46 years, with a range from 26 to 56 years.
Statistical Information
Confidence Interval
90% ± 6% for clinical response rate; 32% ± 10% for pathological complete response rate.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website